Table 2 HCV Antibody status by duration of injection drug use (IDU) at time of testing.

None

148/1726 (8.6%)

1 year

5/9 (55.6%)

59/151 (39.1%)

2 years

5/8 (62.5%)

56/104 (53.8%)

3 years

6/11 (54.5%)

59/104 (56.7%)

4–5 years

13/20 (65.0%)

138/209 (66.0%)

6–7 years

15/21 (71.4%)

148/202 (73.3%)

8–10 years

33/43 (76.7%)

275/335 (82.1%)

11–15 years

84/102 (82.4%)

360/439 (82.0%)

16–20 years

91/109 (83.5%)

497/556 (89.4%)

21–30 years

167/184 (90.8%)

1345/1394 (96.5%)

> 30 years

15/15 (100%)

1110/1129 (98.3%)